What is the current cutaneous radiation injury treatment market size?

The cutaneous radiation injury treatment market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the cutaneous radiation injury treatment market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the cutaneous radiation injury treatment market?

Key drivers include rising radiation exposure incidents and advancements in treatment technologies.

What are the major challenges facing the cutaneous radiation injury treatment market?

Challenges include high treatment costs and limited awareness about available treatments.

Which regions are leading the cutaneous radiation injury treatment market?

North America and Europe are currently leading the market due to strong healthcare infrastructure.

Who are the top companies in the cutaneous radiation injury treatment market?

Top companies include Johnson & Johnson, Pfizer, and Roche, which offer a range of treatment products.

What future opportunities exist in the cutaneous radiation injury treatment market?

Future opportunities include development of new treatments and expansion into emerging markets.

How is technology impacting the cutaneous radiation injury treatment market?

Technology is improving treatment outcomes and patient care through advanced diagnostic and therapeutic tools.

What is the current regulatory landscape for the cutaneous radiation injury treatment market?

The regulatory landscape is governed by strict guidelines to ensure safe and effective treatment products.

What is the future outlook for the cutaneous radiation injury treatment market?

The future outlook is positive, with growing demand and advancements in treatment technologies expected.

cutaneous radiation injury treatment Value Chain Analysis & Forecast Outlook 2033

cutaneous radiation injury treatment by Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others), by Types (Nonsteroidal Anti-inflammatory Drugs, Antihistamine, Antibiotics, Corticosteroids, Others) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

cutaneous radiation injury treatment Market Size | CAGR 7.2 Forecast 2033

cutaneous radiation injury treatment Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

cutaneous radiation injury treatment Market Overview

The cutaneous radiation injury treatment market refers to the industry focused on developing and providing treatments for skin injuries caused by radiation exposure. As the cutaneous radiation injury treatment market size is expected to grow significantly, driven by an increasing number of nuclear accidents and rising awareness about radiation safety, the growth outlook and market forecast are becoming increasingly important for industry stakeholders. The industry expansion is anticipated to be driven by advancements in medical technology, stringent regulations, and shifting consumer behavior, with the global market estimated to be around $373.8 million in 2025.

Loading chart…

The cutaneous radiation injury treatment market is expected to grow at a CAGR of 7.3% from 2026 to 2033, driven by macro drivers such as an increasing number of nuclear accidents, advancements in medical technology, and rising awareness about radiation safety. Key forces shaping the industry include technology shifts towards more effective treatments, regulations related to radiation safety, and competitive intensity among market players. The largest region in the market is North America, while the fastest-growing region is Asia-Pacific. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to make informed decisions.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Merck; Novartis; Johnson & Johnson; Pfizer; Amgen; Roche; Eli Lilly and Company; AstraZeneca; Teva Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The cutaneous radiation injury treatment market is poised for significant growth, driven by increasing demand for effective treatments and advancements in medical technology. The cutaneous radiation injury treatment market size is expected to expand rapidly, with a substantial growth forecast over the next few years.

Growth Drivers2 items

Rising incidence of nuclear accidents and radiation exposure, leading to a growing need for effective cutaneous radiation injury treatments

Advances in medical technology, such as the development of novel topical creams and dressings, are driving innovation in the cutaneous radiation injury treatment market

Restraints2 items

High costs associated with research and development, as well as the regulatory hurdles involved in bringing new treatments to market, are limiting the growth of the cutaneous radiation injury treatment market

Limited awareness and understanding of cutaneous radiation injury treatments among healthcare professionals and patients are hindering the adoption of these treatments

Opportunities2 items

Increasing investment in research and development, particularly in the areas of radiation protection and wound healing, is expected to drive innovation and growth in the cutaneous radiation injury treatment market

Growing demand for cutaneous radiation injury treatments in emerging markets, driven by increasing access to healthcare and rising awareness of these conditions, presents a significant opportunity for market players

Challenges2 items

Ensuring the cutaneous radiation injury treatment market size grows sustainably, while addressing the complex challenges associated with radiation exposure, is a key concern for market players and regulators

Balancing the need for effective treatments with the need for cost containment and accessibility is a significant challenge in the cutaneous radiation injury treatment market, particularly in resource-constrained settings

Market Segmentation

Loading chart…

The Application segment in the cutaneous radiation injury treatment market refers to the various uses of treatments for cutaneous radiation injuries. This market segmentation is crucial in understanding the demand for different treatment applications, such as hospital and clinical settings. The application segment contributes significantly to the overall cutaneous radiation injury treatment market size, as it encompasses the primary uses of these treatments. The cutaneous radiation injury treatment segmentation by application provides valuable insights into the market dynamics, helping stakeholders to identify opportunities and challenges.

The Types segment in the cutaneous radiation injury treatment market includes subtypes such as [object Object] and [object Object]. This segmentation category is essential in understanding the different types of treatments available for cutaneous radiation injuries. By analyzing the types segment, stakeholders can gain insights into the market taxonomy and identify areas with high growth potential. The types segment is a critical component of the overall cutaneous radiation injury treatment market size, as it encompasses the various treatment options available to patients.

cutaneous radiation injury treatment Segmentation Breakdown11 items

Application

Hospitals

Clinics

Ambulatory Surgical Centers

Others

Types

Nonsteroidal Anti-inflammatory Drugs

Antihistamine

Antibiotics

Corticosteroids

Others

Regional Insights

Loading chart…

The cutaneous radiation injury treatment market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include policies supporting research and development, a skilled workforce, and a strong investment climate. Asia Pacific's growth is fueled by a large and growing population, increasing adoption of innovative treatments, and rising investments in healthcare. Latin America's growth is driven by improving infrastructure, expanding ecosystem maturity, and government policies supporting healthcare development. The Middle East & Africa region is expected to experience growth due to increasing adoption of advanced technologies and rising investments in healthcare infrastructure.

The regional forecast indicates that the cutaneous radiation injury treatment market will experience significant growth in the coming years, driven by these regional factors. Understanding the unique characteristics and drivers of each region is crucial for stakeholders to navigate the cutaneous radiation injury treatment market growth and capitalize on emerging opportunities.

Competitive Landscape

The cutaneous radiation injury treatment market is moderately consolidated, with a mix of global players and local companies competing for market share. The cutaneous radiation injury treatment competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are concentrating on regional expansion and localization.

Companies in this market are employing various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies are adopting different strategies to stay ahead in the market:

Merck: regional expansion

Novartis: innovation pipeline

Johnson & Johnson: premium pricing

Pfizer: OEM tie-ups

Amgen: local manufacturing

Roche: vertical integration

Key cutaneous radiation injury treatment Companies9 items

Merck

Novartis

Johnson & Johnson

Pfizer

Amgen

Roche

Eli Lilly and Company

AstraZeneca

Teva Pharmaceuticals

Market Ecosystem

The cutaneous radiation injury treatment ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. Value is created and captured as technology and components are integrated, distributed, and ultimately used to treat cutaneous radiation injuries. This ecosystem can be broadly segmented into three main areas: upstream, where raw materials and components are sourced; midstream, where these inputs are integrated into treatments; and downstream, where channels and end users interact.

Raw material/component suppliers — provide essential materials

Technology providers — develop treatment technologies

OEMs / manufacturers — produce treatment products

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance

End users / buyers — receive cutaneous radiation injury treatments

Regulators/standards bodies — establish treatment standards and approvals

In the cutaneous radiation injury treatment ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through stringent approvals and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards that must be met. Switching costs and interoperability requirements can also pose challenges. As part of a thorough value chain analysis, understanding these dynamics is crucial to navigating the cutaneous radiation injury treatment ecosystem, which may differ by region due to varying regulatory environments and treatment protocols.

Recent Industry Insights

The cutaneous radiation injury treatment industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between pharmaceutical companies and research institutions, have focused on developing innovative treatments for cutaneous radiation injuries. Additionally, there have been notable mergers and acquisitions, with companies expanding their product portfolios to cater to the growing demand for effective treatments. Furthermore, several product launches have taken place, introducing new technologies and therapies to the market.

Regulatory changes have also played a crucial role in shaping the industry, with updates to guidelines and protocols for treating cutaneous radiation injuries. A shift in consumer trends has been observed, with an increasing emphasis on personalized medicine and targeted therapies. Funding rounds and expansions have been secured by several companies, enabling them to invest in research and development and drive growth in the cutaneous radiation injury treatment market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the cutaneous radiation injury treatment market. The cutaneous radiation injury treatment market outlook is promising, driven by increasing demand for effective treatments. The market attractiveness is moderate, with opportunities for growth in emerging economies. Competitive intensity is high, with key players investing in research and development to improve treatment options.

The long-term outlook is positive, with innovations in radiation therapy and wound care expected to drive growth. The demand-supply balance is currently skewed, with a shortage of effective treatments. Key risk factors include regulatory challenges and pricing pressures. Overall, the cutaneous radiation injury treatment market offers opportunities for growth and innovation, despite challenges.

11 items

1. Executive Summary

2. cutaneous radiation injury treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global cutaneous radiation injury treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global cutaneous radiation injury treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Ambulatory Surgical Centers

6.1.4. Others

6.2. Global cutaneous radiation injury treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Nonsteroidal Anti-inflammatory Drugs

6.2.2. Antihistamine

6.2.3. Antibiotics

6.2.4. Corticosteroids

6.2.5. Others

6.3. Global cutaneous radiation injury treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global cutaneous radiation injury treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global cutaneous radiation injury treatment Market by: Regions (Value)

8. Global cutaneous radiation injury treatment Market Competition by Key Manufacturers

8.1. Global cutaneous radiation injury treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global cutaneous radiation injury treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Novartis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Johnson & Johnson

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Pfizer

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Amgen

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Roche

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Eli Lilly and Company

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. AstraZeneca

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Teva Pharmaceuticals

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global cutaneous radiation injury treatment Market

Figure 4: Global cutaneous radiation injury treatment Market: Drivers

Figure 5: Global cutaneous radiation injury treatment Market: Challenges

Figure 6: Global cutaneous radiation injury treatment Market: Trends

Figure 7: Global cutaneous radiation injury treatment Market: Opportunity

Figure 8: Global cutaneous radiation injury treatment Market: Restraint

Figure 9: Global cutaneous radiation injury treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global cutaneous radiation injury treatment Market Value (USD Million) By Region

Figure 15: Global cutaneous radiation injury treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global cutaneous radiation injury treatment Market Value (USD Million) By Region

Figure 23: Global cutaneous radiation injury treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global cutaneous radiation injury treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global cutaneous radiation injury treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global cutaneous radiation injury treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global cutaneous radiation injury treatment Market Value (USD Million) By Region

Table 10: Global cutaneous radiation injury treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global cutaneous radiation injury treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global cutaneous radiation injury treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global cutaneous radiation injury treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck Basic Information And Sales Area

Table 31: Merck. Products Portfolio

Table 32: Novartis Basic Information And Sales Area

Table 33: Novartis. Products Portfolio

Table 34: Johnson & Johnson Basic Information And Sales Area

Table 35: Johnson & Johnson. Products Portfolio

Table 36: Pfizer Basic Information And Sales Area

Table 37: Pfizer. Products Portfolio

Table 38: Amgen Basic Information And Sales Area

Table 39: Amgen. Products Portfolio

Table 40: Roche Basic Information And Sales Area

Table 41: Roche. Products Portfolio

Table 42: Eli Lilly and Company Basic Information And Sales Area

Table 43: Eli Lilly and Company. Products Portfolio

Table 44: AstraZeneca Basic Information And Sales Area

Table 45: AstraZeneca. Products Portfolio

Table 46: Teva Pharmaceuticals Basic Information And Sales Area

Table 47: Teva Pharmaceuticals. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global cutaneous radiation injury treatment Market Value (USD Million) By Region

Table 53: Global cutaneous radiation injury treatment Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

cutaneous radiation injury treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Merck; Novartis; Johnson & Johnson; Pfizer; Amgen; Roche; Eli Lilly and Company; AstraZeneca; Teva Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options